||FOR RESEARCH USE ONLY (RUO).
||Recombinant-2019 nCoV/COVID19 RBD-hFc-Tag protein was developed from cho cells and has a target region of hFc-Tag. For use in research applications.
||Recombinant COVID-19 RBD (Receptor Binding Domain) protein was lyophilized from 0.2 µm filtered 20 mM Tris, 300 mM NaCl, 10 % glycerol, pH 8.0.
||Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers.
||The lyophilized protein is stable for at least 2 years from date of receipt at-20°C.
||Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
| Background || Recombinant 2019-nCoV RBD protein is a protein consisting of 460 amino acid residues, due to glycosylation migrates as an approximately 70 kDa protein on SDS-PAGE. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance